Malaria control activities in West and Central Africa have resulted in a substantial decrease in the incidence of malaria during the last five years. Despite these successes, new challenges such as the emergence of insecticide and drug resistance, a shift in the age groups most at risk, the maintenance of transmission at unidentified malaria hot spots and, lastly, difficulties in deciding the most cost-effective combinations of interventions call for additional research to better target existing interventions and identify new ones. In this changing environment, a new world-class generation of African scientists able to provide relevant answers to the challenges encountered by National Malaria Control Programmes is needed, possibly contributing towards the point where elimination becomes a realistic target in the near future.
The Malaria Research Capacity Development (MARCAD) Consortium in West and Central Africa is launching a new PhD and Post Doc programme in the thematic areas of Malaria Elimination or Control/Scale up of Interventions. MARCAD is a group of institutions sponsored by the Wellcome Trust working in partnership with the Department of International Development and the Alliance for Accelerating Excellence in Science in Africa (AESA). The University Cheikh Anta Diop (UCAD), Senegal is the leading institution working with the University Health &Allied Sciences (UHAS)in Ghana; the University of Yaoundé 1 (UYI), Cameroun; the Medical Research Council Unit, The Gambia (MRCG), and the Malaria Research & Training Center (MRTC), Mali.
The program seeks to train African scientists toward building a critical mass for the control and the elimination of malaria, equip them to compete effectively for international funding, offer them international exposure, and facilitate their networking and collaboration with other institutions. These goals will be met by focusing on postdoctoral fellows and their progression to senior researchers/research leaders. PhD fellowships will be awarded competitively to promising young researchers, supervised by postdoctoral fellows and senior scientists from research teams in the established participating institutions. Fellowships may be held at one of the five African-based institutions and additionally, students will receive support from the Liverpool School of Tropical Medicine (LSTM), the London School of Hygiene & Tropical Medicine (LSHTM) or the University of Copenhagen (UoC).
MARCAD OFFERS:
1 Example of on-going research programs in partnering institutions
Institution/Country |
Research topic |
University Cheikh Anta Diop Senegal |
Monitoring resistance , Molecular markers studies |
Malaria elimination program targetting hot spot |
|
Primaquine safety study |
|
Assessing SMC impact Impact of resistance on the effectiveness of vector control strategies Malaria Diagnostics Malaria & Comorbidities |
|
c |
|
University of Health & Allied Sciences, Ghana |
Malaria in pregnancy: effectiveness of recommended routine antenatal interventions for pregnant women |
Malaria and other parasitic infections during pregnancy: Burden, potential effects and prospects for community intervention programmes |
|
|
|
Malaria Research Training Centre, Mali |
Effect of SMC in malaria among school children |
Transmissibility of gametocyte after treatment with ACT |
|
Bio-informatic training program Clinical trials on malaria vaccine: Phase Ib/II trials Impact of gut microbiome on malaria immunity |
|
|
|
University of Yaounde I, Cameroon |
|
Modelling Optimal Configurations of Interventions for Cost-Effective Malaria Elimination. |
|
Malaria Elimination: Pharmacological Indices during MDA in co-endemicities with NCDs & NTDs |
|
Pharmaco-genomics: Mapping of the Evolution of Markers of Resistance and Human responses/adverse drug reactions in areas with on going clinical trial research activities in Malaria |
|
|
|
University of Copenhagen, Denmark |
Improving access to ACT and RDT |
Monitoring drug quality |
|
Monitoring resistance, molecular markers of drug resistance Acquired immunity in children and during pregnancy, Pathogenesis of malaria |
|
|
|
London School of Hygiene and Tropical Medicine UK |
London School Informal National Malaria Control programme Knowledge project |
Assessing drug safety in high risk group |
|
SMC plus azithromycin trial |
|
|
|
Malaria Research Centre, Gambia MRCG, The Gambia |
Cluster randomized trials on interventions aiming at interrupting transmission Dynamics of malaria transmission in areas of low to moderate transmission |
Malaria Diagnostic |
|
|
Surveillance of drug and insecticide resistance |
|
Malaria in pregnancy |
|
|
Liverpool School of Tropical Medicine UK |
Impact of resistance on the effectiveness of vector control strategies Impact of insecticide resistance on immune response Testing of new vector control tools |
|
Resistance Markers for A. funestus, gambiae, Culex (not only KDR) |
|
|
2 MARCAD Fellowships
a) Five four-year PhDs fellowships will be offered which will cover: stipend, tuition fees, the costs of up to 6 months spent with a European partner University and research expenses for the project.
b) Ten three-years Post-Docs fellowships which will cover: stipend, tuition fees, the costs of up to 3 months spent with a European partner University and research expenses for the project.
The programme will also encourage the development of research teams, in which both PhD and Post-Docs fellows can be integrated.
Fellowships may be held at one of the five African universities. Applicants must be African nationals resident in a malaria endemic country of Africa or in the diaspora and have an intention to pursue a long-term career in malaria research.
Female gender are strongly encouraged to apply ; social science candidates are welcome to apply.
Further information on the programmecan be obtained bycontacting the MARCAD
Secretariat at UCAD (This email address is being protected from spambots. You need JavaScript enabled to view it.) & Pr Oumar Gaye (This email address is being protected from spambots. You need JavaScript enabled to view it.).
MARCAD Consortium Secretariat
Faculty of Medicine, Pharmacy and Odontology
University Cheikh Anta Diop (UCAD) of Dakar, Senegal